This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Scientists are hopeful that a new drug — called EIDD-2801 — could change the way...
Credit: Fernando Racimo Neolithic populations have long been credited with bringing...
A phase 1 trial of Moderna’s COVID-19 vaccine candidate has begun enrolling subjects...
A study of Regeneron and Sanofi's Kevzara will continue, but only for patients in...
Aslan has seen multiple trial flops, restructuring and cuts over the past few years;...
Wellcome Leap nabs $300M, ex-DARPA, Illumina execs to battle global health problems...
Credit: UNIST An international team of researchers, affiliated with UNIST has for...
The French VC firm Sofinnova Partners has invested €20M in three Italian biotech...
A combination of Opdivo with Exelixis' Cabometyx, if cleared for use, would compete...